These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37712059)

  • 21. Age-dependent NK cell dysfunctions in severe COVID-19 patients.
    Fionda C; Ruggeri S; Sciumè G; Laffranchi M; Quinti I; Milito C; Palange P; Menichini I; Sozzani S; Frati L; Gismondi A; Santoni A; Stabile H
    Front Immunol; 2022; 13():1039120. PubMed ID: 36466890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.
    Witkowski M; Tizian C; Ferreira-Gomes M; Niemeyer D; Jones TC; Heinrich F; Frischbutter S; Angermair S; Hohnstein T; Mattiola I; Nawrath P; McEwen S; Zocche S; Viviano E; Heinz GA; Maurer M; Kölsch U; Chua RL; Aschman T; Meisel C; Radke J; Sawitzki B; Roehmel J; Allers K; Moos V; Schneider T; Hanitsch L; Mall MA; Conrad C; Radbruch H; Duerr CU; Trapani JA; Marcenaro E; Kallinich T; Corman VM; Kurth F; Sander LE; Drosten C; Treskatsch S; Durek P; Kruglov A; Radbruch A; Mashreghi MF; Diefenbach A
    Nature; 2021 Dec; 600(7888):295-301. PubMed ID: 34695836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cells in antiviral immunity.
    Björkström NK; Strunz B; Ljunggren HG
    Nat Rev Immunol; 2022 Feb; 22(2):112-123. PubMed ID: 34117484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Frequencies of Phenotypically and Functionally Senescent and Exhausted CD56
    Srivastava R; Dhanushkodi N; Prakash S; Coulon PG; Vahed H; Zayou L; Quadiri A; BenMohamed L
    bioRxiv; 2022 Jul; ():. PubMed ID: 35923316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56
    Gentili V; Bortolotti D; Morandi L; Rizzo S; Schiuma G; Beltrami S; Casciano F; Papi A; Contoli M; Zauli G; Rizzo R
    Front Biosci (Landmark Ed); 2023 Jul; 28(7):156. PubMed ID: 37525920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
    Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
    Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 infection impairs NK cell functions
    Lenart M; Górecka M; Bochenek M; Barreto-Duran E; Szczepański A; Gałuszka-Bulaga A; Mazur-Panasiuk N; Węglarczyk K; Siwiec-Koźlik A; Korkosz M; Łabaj PP; Baj-Krzyworzeka M; Siedlar M; Pyrc K
    Front Immunol; 2023; 14():1123155. PubMed ID: 37287972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.
    Herrera L; Martin-Inaraja M; Santos S; Inglés-Ferrándiz M; Azkarate A; Perez-Vaquero MA; Vesga MA; Vicario JL; Soria B; Solano C; De Paz R; Marcos A; Ferreras C; Perez-Martinez A; Eguizabal C
    Immunology; 2022 Feb; 165(2):234-249. PubMed ID: 34775592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients.
    Gabr H; Abdel Aal AA; Bastawy S; Fateen M; Abd El Dayem OY; Youssef EA; Afifi R; Kamal M
    Viral Immunol; 2023 May; 36(4):250-258. PubMed ID: 36847755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth.
    Carbonnel M; Daclin C; Tarantino N; Groiseau O; Morin V; Rousseau A; Vasse M; Hertig A; Kennel T; Ayoubi JM; Vieillard V
    Front Immunol; 2022; 13():893450. PubMed ID: 35911747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines
    Ma MT; Badeti S; Chen CH; Kim J; Choudhary A; Honnen B; Reichman C; Calianese D; Pinter A; Jiang Q; Shi L; Zhou R; Xu H; Li Q; Gause W; Liu D
    Front Immunol; 2021; 12():652223. PubMed ID: 34367128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune modulation as a consequence of SARS-CoV-2 infection.
    Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
    Front Immunol; 2022; 13():954391. PubMed ID: 36110850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 and IL-2 mediated NK cell responses after COVID-19 infection and mRNA vaccination in adults.
    Alhajjat AM; Redden CR; Langereis M; Papastefan ST; Ito JAS; Ott KC; Turner LE; Kang HK; Shaaban AF
    Immunobiology; 2023 Jan; 228(1):152304. PubMed ID: 36508885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial mass of circulating NK cells as a novel biomarker in severe SARS-CoV-2 infection.
    Wang B; Chen Z; Huang Y; Ding J; Lin Y; Wang M; Li X
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110839. PubMed ID: 37639852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.